Randomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosis.
Pinder, Emma M
Randomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosis. [electronic resource] - Thorax 10 2018 - 918-925 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1468-3296
10.1136/thoraxjnl-2017-211323 doi
Adult
Aged
Aged, 80 and over
Critical Illness--therapy
Female
Granulocyte-Macrophage Colony-Stimulating Factor--adverse effects
HLA-DR Antigens--metabolism
Humans
Male
Middle Aged
Monocytes--metabolism
Neutrophils--drug effects
Phagocytosis--drug effects
Treatment Outcome
Randomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosis. [electronic resource] - Thorax 10 2018 - 918-925 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1468-3296
10.1136/thoraxjnl-2017-211323 doi
Adult
Aged
Aged, 80 and over
Critical Illness--therapy
Female
Granulocyte-Macrophage Colony-Stimulating Factor--adverse effects
HLA-DR Antigens--metabolism
Humans
Male
Middle Aged
Monocytes--metabolism
Neutrophils--drug effects
Phagocytosis--drug effects
Treatment Outcome